{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:35:26Z","timestamp":1775975726365,"version":"3.50.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Pregnant patients with inflammatory bowel diseases (IBDs) are frequently treated with immunomodulatory agents and may be at increased risk of adverse outcomes, including peripartum infections. We sought to examine the risk for peripartum infections in patients with IBD compared with control subjects and identify potential risk factors associated with peripartum infections in these patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective cohort study compared peripartum infection rates and associated risk factors between pregnant women with and without IBD. The study population included women attending a dedicated joint maternal-fetal medicine and gastroenterology clinic for pregnant women with IBD between 2012 and 2019 at the Rabin Medical Center in Israel, a major referral center for patients with IBD. For each patient, 5 women without IBD were matched according to the newborn\u2019s birth date (\u00b12 years), age, parity, and body mass index. Peripartum infection was defined as any 1 of the following: chorioamnionitis, maternal fever (&amp;gt;38\u00b0C) detected during labor or postpartum hospitalization, and positive culture taken during the hospitalization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 195 pregnant women with IBD (72 [37%] with ulcerative colitis, 123 [63%] with Crohn\u2019s disease) were matched with 888 control subjects. The mean disease duration was 8.4\u2005\u00b1\u20057.02 years. IBD therapy, used by 81%, included most frequently 5-aminosalicylic acid (44%) and tumor necrosis factor inhibitors (27%). Peripartum infections were observed in 15 (7.7%) patients and 49 (5.5%) control subjects (P\u2005=\u20051.00). No medication significantly increased the likelihood of peripartum infection. Cesarean delivery was more likely among women with IBD but was not associated with an increased risk of peripartum infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Peripartum infections were comparable in patients with IBD and control subjects. These reassuring data augment existing knowledge of obstetrical outcomes in IBD patients and contribute to the discussion between caregivers and patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izac185","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T18:13:30Z","timestamp":1662056010000},"page":"1098-1104","source":"Crossref","is-referenced-by-count":3,"title":["Peripartum Infections Among Women With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"29","author":[{"given":"Bar","family":"Narkis","sequence":"first","affiliation":[{"name":"Helen Schneider Hospital for Women, Rabin Medical Center , Petah-Tikva , Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eran","family":"Hadar","sequence":"additional","affiliation":[{"name":"Helen Schneider Hospital for Women, Rabin Medical Center , Petah-Tikva , Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiri","family":"Barbash-Hazan","sequence":"additional","affiliation":[{"name":"Helen Schneider Hospital for Women, Rabin Medical Center , Petah-Tikva , Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ohad","family":"Houri","sequence":"additional","affiliation":[{"name":"Helen Schneider Hospital for Women, Rabin Medical Center , Petah-Tikva , Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vardit","family":"Shay","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"},{"name":"Division of Gastroenterology, Rabin Medical Center , Petah Tikva , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob E","family":"Ollech","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"},{"name":"Division of Gastroenterology, Rabin Medical Center , Petah Tikva , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henit","family":"Yanai","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"},{"name":"Division of Gastroenterology, Rabin Medical Center , Petah Tikva , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Dotan","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"},{"name":"Division of Gastroenterology, Rabin Medical Center , Petah Tikva , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9142-6530","authenticated-orcid":false,"given":"Irit","family":"Avni-Biron","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"},{"name":"Division of Gastroenterology, Rabin Medical Center , Petah Tikva , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"issue":"1","key":"2023070506290025500_CIT0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment.","volume":"14","author":"Torres","year":"2020","journal-title":"J Crohn\u2019s Colitis"},{"issue":"2","key":"2023070506290025500_CIT0002","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ecco-jcc\/jjaa161","article-title":"The medical management of paediatric Crohn\u2019s disease: an ECCO-ESPGHAN guideline update.","volume":"15","author":"Van Rheenen","year":"2021","journal-title":"J Crohn\u2019s Colitis"},{"issue":"7","key":"2023070506290025500_CIT0003","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1572-0241.2006.00603.x","article-title":"The epidemiology of inflammatory bowel disease in Canada: a population-based study","volume":"101","author":"Bernstein","year":"2006","journal-title":"Am J Gastroenterol."},{"issue":"6","key":"2023070506290025500_CIT0004","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and prevalence of Crohn\u2019s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010","volume":"15","author":"Shivashankar","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"10114","key":"2023070506290025500_CIT0005","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet."},{"key":"2023070506290025500_CIT0006","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2018.12.022","article-title":"Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD parenthood project working group","volume":"156","author":"Mahadevan","year":"2019","journal-title":"Gastroenterology."},{"issue":"11","key":"2023070506290025500_CIT0007","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cgh.2012.08.018","article-title":"Complications from inflammatory bowel disease during pregnancy and delivery","volume":"10","author":"Br\u00f6ms","year":"2012","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"2","key":"2023070506290025500_CIT0008","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","article-title":"The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease","volume":"9","author":"van der Woude","year":"2015","journal-title":"J Crohns Colitis."},{"issue":"11","key":"2023070506290025500_CIT0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.10.035","article-title":"Effective treatment of acute severe ulcerative colitis in pregnancy is associated with good maternal and fetal outcomes","volume":"19","author":"Ollech","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"2023070506290025500_CIT0010","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0002-9378(97)70298-9","article-title":"Pregnancy outcomes in women with inflammatory bowel disease\u2014a population-based cohort study","volume":"177","author":"Kornfeld","year":"1997","journal-title":"Am J Obstet Gynecol."},{"issue":"6","key":"2023070506290025500_CIT0011","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.2006.108324","article-title":"A meta-analysis on the influence of inflammatory bowel disease on pregnancy","volume":"56","author":"Cornish","year":"2007","journal-title":"Gut."},{"key":"2023070506290025500_CIT0012","first-page":"311","article-title":"Birthweight standards in the live-born population in Israel","volume":"7","author":"Dolberg","year":"2005","journal-title":"Isr Med Assoc J."},{"issue":"3","key":"2023070506290025500_CIT0013","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/apt.15587","article-title":"Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease","volume":"51","author":"Tandon","year":"2020","journal-title":"Aliment Pharmacol Ther."},{"issue":"12","key":"2023070506290025500_CIT0014","doi-asserted-by":"crossref","first-page":"e1002984e1002984","DOI":"10.1371\/journal.pmed.1002984","article-title":"Incidence of maternal peripartum infection: a systematic review and meta-analysis","volume":"16","author":"Woodd","year":"2019","journal-title":"PLoS Med."},{"issue":"6","key":"2023070506290025500_CIT0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ibd\/izab165","article-title":"Peripartum exposure to biologic therapy does not impact postpartum wound healing in women with IBD","volume":"28","author":"Aboubakr","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"11","key":"2023070506290025500_CIT0016","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41395-018-0176-7","article-title":"Continuous Anti-TNF\u03b1 use throughout pregnancy: possible complications for the mother but not for the fetus. A retrospective cohort on the French National Health Insurance Database (EVASION)","volume":"113","author":"Luu","year":"2018","journal-title":"Am J Gastroenterol."},{"issue":"11","key":"2023070506290025500_CIT0017","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/1471-0528.13946","article-title":"Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes","volume":"123","author":"Shand","year":"2016","journal-title":"BJOG."},{"issue":"3","key":"2023070506290025500_CIT0018","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cgh.2008.10.022","article-title":"Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States","volume":"7","author":"Nguyen","year":"2009","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"2023070506290025500_CIT0019","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.gastro.2020.11.038","article-title":"Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease","volume":"160","author":"Mahadevan","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"2023070506290025500_CIT0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/apt.15587","article-title":"Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease","volume":"51","author":"Tandon","year":"2020","journal-title":"Aliment Pharmacol Ther."},{"issue":"8","key":"2023070506290025500_CIT0021","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s10620-017-4547-5","article-title":"Inadequate gestational weight gain predicts adverse pregnancy outcomes in mothers with inflammatory bowel disease: results from a prospective US pregnancy cohort","volume":"62","author":"Bengtson","year":"2017","journal-title":"Dig Dis Sci."},{"issue":"5","key":"2023070506290025500_CIT0022","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/apt.12412","article-title":"The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women","volume":"38","author":"Pedersen","year":"2013","journal-title":"Aliment Pharmacol Ther."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izac185\/45649424\/izac185.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/29\/7\/1098\/50693853\/izac185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/29\/7\/1098\/50693853\/izac185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T16:35:37Z","timestamp":1688574937000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/29\/7\/1098\/6682832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,9,1]]},"published-print":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izac185","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2022,9,1]]}}}